Abstract:Glucose-6-phosphate dehydrogenase (G6PD) deficiency is an X-linked recessive Mendelian genetic disorder characterized by neonatal jaundice and hemolytic anemia, affecting more than 400 million people worldwide. The purpose of this research was to investigate prevalence rates of G6PD deficiency and to evaluate and establish specific cut-off values in early prediction of G6PD deficiency by regions (HeFei, FuYang, AnQing) on different seasons, as well as to investigate the frequencies of G6PD gene mutations among three regions mentioned above.A total of 31,482 neonates (21,402, 7680, and 2340 for HeFei, FuYang, and AnQing cities, respectively) were recruited. Positive subjects were recalled to attend genetic tests for diagnosis. G6PD activity on the Genetic screening processor (GSP analyzer, 2021-0010) was measured following the manufactureržs protocol. The cut-off value was first set to 35 U/dL. The receiver operating characteristics (ROC) curve was employed to assess and compare the efficiency in predicting G6PD deficiency among HeFei, FuYang, and AnQing cities in different seasons.Nedostatak glukoza-6-fosfat dehidrogenaze (G6PD) je recesivni Mendelov genetski poremećaj povezan sa X hromozomom koji karakteriše neonatalna žutica i hemolitička anemija, koji pogađa više od 400 miliona ljudi širom sveta. Svrha ovog istraživanja je bila da se istraže stope prevalencije nedostatka G6PD i da se procene i utvrde specifične granične vrednosti u ranom predviđanju nedostatka G6PD po regionima (HeFei, FuIang, AnKing) u različitim godišnjim dobima, kao i da se ispita učestalost G6PD genske mutacije u okviru tri gore pomenuta regiona.Ukupno je uključeno 31.482 novorođenčadi (21.402, 7.680 i 2.340 za gradova HeFei, FuYang i AnQing). Pozitivni subjekti su pozvani da prisustvuju genetskim testovima radi postavljanja dijagnoze. Aktivnost G6PD na procesoru genetskog skrininga (GSP analizator, 2021-0010) je merena prema protokolu proizvođača. Granična vrednost je prvo postavljena na 35 U/dL. Kriva radnih karakteristika prijemnika (ROC) je korišćena da se proceni i uporedi efikasnost u predviđanju nedostatka G6PD u gradovima HeFei, FuYang i AnQing u različitim godišnjim dobima.Na nedostatak G6PD je testirano 31,482 novorođenčadi, a 29 novorođenčadi je identifikovano sa nedo statkom G6PD, sa stopom prevalencije od 0,09%. Stopa incidencije nedostatka G6PD je bila 0,10% (22/21.380) za HeFei, 0,04% (3/7.667) za FuYang i 0,17% (4/2.396) za AnQing. Optimalne granične vrednosti ROC krive u predviđanju nedostatka G6PD su bile 26,55 U/dL za HeFei (proleće: 21,80 U/dL, leto: 26,55 U/dL, zima: 23,16 U/dL), 6,35 U/dL za grad FuYang, 7,15 U/dL za AnQing. R463H (17/57, 29,82%) je bila najčešća varijacija, zatim R459L (15/57, 26,31%), H32R (8/57, 14,04%), L342F (6/57, 10,53%), V291M (6/57, 10,53%).Ustanovili smo optimalne granične vrednosti G6PD aktivnosti u predviđanju nedostatka G6PD u gradovima HeFei, FuYang i AnQing u različitim godišnjim dobima. Ovo će pomoći u ranom otkrivanju nedostatka G6PD kod novorođenčadi u gore pomenutim regionima. Takođe smo istražili prevalence po regionima i otkrili mutacije frekvencije. Ovi rezultati će pomoći u promociji G6PD skrininga i postavljanju precizne dijagnoze za provinciju Anhui.

Analysis of Glucose-6-phosphate Dehydrogenase Concentration in 29 527 Newborns in Kunming Areas

Chinese Newborn Screening for the Incidence of G6PD Deficiency and Variant of G6PD Gene from 2013 to 2017

Prevalence of Glucose-6-Phosphate Dehydrogenase Deficiency in Sichuan, China

Chinese Newborn Screening for G6PD Deficiency, with Activity and Gene

Analysis of Newborn Umbilical Cord Blood Glucose-6-phosphate Dehydrogenase Screening Results of 646 Cases in Zhongshan Xiaolan Region

Detection and Analysis of G6PD Deficiency in Qinzhou Area, Guangxi Guangxi Zhuang Autonomous Region

Molecular genotyping of G6PD mutations for neonates in Ningbo area

Anaiysis of screening for neonate with G6PD deficiency

Molecular diagnosis and mutation identification in newborn with glucose-6-phosphate dehydrogenase deficiency by DNA sequencing

Evaluation of Strategies for Identification of Infants with Pathogenic Glucose-6-phosphate Dehydrogenase Variants in China

Molecular neonatal screening for glucose-6-phosphate dehydrogenase deficiency in Guiyang region

Analysis of factors infecting result of neonatal dried blood G 6PD screening test

Detection of gene mutation in heterozygous of glucose-6-phosphate dehydrogenase deficiency by multicolor melting curve analysis

Screening and the analysis of genotypic and phenotypic characterization of glucose-6-phosphate dehydrogenase (G6PD) deficiency in Fujian province, China

Molecular Characterization of Glucose-6-Phosphate Dehydrogenase Deficiency in the Shenzhen Population

Genotypic and phenotypic characterization of glucose-6-phosphate dehydrogenase (G6PD) deficiency in Guangzhou, China

Rapid and Reliable Detection of Glucose-6-phosphate Dehydrogenase (G6PD) Gene Mutations in Han Chinese Using High-Resolution Melting Analysis.

Molecular epidemiological characteristics, variant spectrum and genotype-phenotype correlation of glucose-6-phosphate dehydrogenase deficiency in China: A population-based multicenter study using newborn screening

Reduction of Missed Diagnosis of G6PD Deficiency in Heterozygous Females by G6PD/6PGD Ratio Assay Combined with Amplification Refractory Mutation System PCR

Molecular epidemiological investigation of G6PD deficiency in Yangjiang region, western Guangdong province

Prevalence,cut-off Values and Variant Spectrum of G6PD Deficien-Cy Patients : Based on a Population-Cohort of 31482 Neonates Fr-Om Newborn Screening among Hefei,Fuyang and Anqing City